Mansoura, Egypt

Seif-Eldin N Ayyad

This inventor holds 1 USPTO granted patent. Top assignee: King Abdulaziz University. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seif-Eldin N Ayyad. Retrieved from https://idiyas.com/inventor/seif-eldin-n-ayyad

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Seif-Eldin N Ayyad: Innovator in Cancer Treatment

Introduction

Seif-Eldin N Ayyad is a notable inventor based in Mansoura, Egypt. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His innovative work has led to the development of a unique pharmaceutical composition that shows promise in combating cancer.

Latest Patents

Seif-Eldin N Ayyad holds a patent for a pharmaceutical composition for treating cancer and a method thereof. This composition contains an anticancer compound known as isopicrinine, which is isolated from a plant. The patent also describes a method of treating cancer using this pharmaceutical composition, as well as a method for extracting isopicrinine. He has 1 patent to his name.

Career Highlights

Ayyad is affiliated with King Abdulaziz University, where he continues to advance his research in pharmaceuticals. His work is characterized by a commitment to developing effective treatments for serious health conditions, particularly cancer.

Collaborations

He has collaborated with notable colleagues, including Jamal Sabir M Sabir and Abdullah Yousef Obaid, to further his research and innovations in the field.

Conclusion

Seif-Eldin N Ayyad is a dedicated inventor whose work in cancer treatment exemplifies the potential of pharmaceutical innovations. His contributions are paving the way for new therapeutic options in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…